Provided by Tiger Fintech (Singapore) Pte. Ltd.

Atara Biotherapeutics

7.11
+0.09001.28%
Post-market: 7.700.5899+8.30%17:27 EDT
Volume:91.38K
Turnover:635.86K
Market Cap:41.66M
PE:-0.62
High:7.21
Open:7.05
Low:6.58
Close:7.02
Loading ...

BUZZ-Atara Biotherapeutics slumps after FDA declines to approve cancer therapy

Reuters
·
16 Jan

Atara Biotherapeutics Shares Resume Trading, Down 45% Premarket After US FDA Declines to Approve Co's Cancer Therapy

THOMSON REUTERS
·
16 Jan

BRIEF-Atara Biotherapeutics Provides Regulatory and Business Update on EBVALLOTM (tabelecleucel)

Reuters
·
16 Jan

US FDA declines to approve Atara Biotherapeutics' cancer therapy

Reuters
·
16 Jan

Atara Biotherapeutics: Intends to Suspend All CAR-T Activities, Significantly Cut Expenses IF Resolution Not Reached for Funding for Programs in Q1

THOMSON REUTERS
·
16 Jan

Atara Biotherapeutics Inc: Crl Did Not Identify Deficiencies Related to Clinical Efficacy or Safety Data in Bla

THOMSON REUTERS
·
16 Jan

Atara Biotherapeutics Inc: Engaged Advisor to Support Exploration of All Strategic Options

THOMSON REUTERS
·
16 Jan

Atara Biotherapeutics Provides Regulatory and Business Update on Ebvallotm (Tabelecleucel)

THOMSON REUTERS
·
16 Jan

Atara Biotherapeutics: Got Into Non-Binding Term Sheet With Redmile Group to Provide up to $15 Mln in Funding

THOMSON REUTERS
·
16 Jan

Atara Biotherapeutics Inc: Received FDA Complete Response Letter (Crl) Solely Related to Inspection Findings at Third-Party Manufacturer

THOMSON REUTERS
·
16 Jan

Atara Biotherapeutics Shares Halted for News Pending Premarket

THOMSON REUTERS
·
16 Jan

Here's Why You Should Consider Buying Atara Biotherapeutics Stock

Zacks
·
08 Jan

Atara Biotherapeutics, Inc.'s (NASDAQ:ATRA) high institutional ownership speaks for itself as stock continues to impress, up 27% over last week

Simply Wall St.
·
08 Jan

Bionano Announces Publication Showing that OGM Identifies Variant that Indicates Use of Proven Therapy in Acute Promyelocytic Leukemia

GlobeNewswire
·
07 Jan

Atara Biotherapeutics (ATRA) Upgraded to Buy: Here's Why

Zacks
·
03 Jan